CD20 (Obinutuzumab biosimilar) Antibody from ICHORBIO

Search, find, compare suppliers for anti-CD20 (Obinutuzumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD20 (Obinutuzumab biosimilar)
Clonemonoclonal
Host SpeciesHumanized
Reactive Specieshuman
IsotypeIgG1
FormatProtein A/G purified, low endotoxin
Size5mg
Concentration1.0 - 5.0 mg/ml
ApplicationsRUO
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: detects human CD20. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Obinutuzumab/afutuzumab. Obinutuzumab biosimilar is a humanized anti-CD20 monoclonal antibody of the IgG1 subclass. It recognizes a specific epitope of the CD20 molecule found on B cells. The molecular mass of the antibody is approximately 150 kDa. it is produced by mammalian cell (CHO) suspension culture. It was engineered for reduced fucose content as compared to a typical IgG1 produced in CHO cells.
Immunogenn/a
Other NamesB-lymphocyte surface antigen B1, Bp35, Leukocyte surface antigen Leu-16, Membrane-spanning 4-domains subfamily A member 1, MS4A1, afutuzumab
Gene, Accession #UniProt: P11836
Catalog #ICH4026-5mg
Price$718
Order / More InfoCD20 (Obinutuzumab biosimilar) Antibody from ICHORBIO
Product Specific Referencesn/a
ICHORBIO
ICHORBIO
ICHORBIO
Boston House, Grove Business Park
Downsview Road
Wantage OX12 9FF ENGLAND

orders@ichor.bio

https://ichor.bio

U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio


Profile of ICHORBIO
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.